Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;128(4):431-445.
doi: 10.1007/s00702-020-02275-y. Epub 2020 Nov 13.

Complex dystonias: an update on diagnosis and care

Rebecca Herzog  1 , Anne Weissbach  1 , Tobias Bäumer  1 , Alexander Münchau  2
Affiliations
Review

Complex dystonias: an update on diagnosis and care

Rebecca Herzog et al. J Neural Transm (Vienna). 2021 Apr.

Abstract

Complex dystonias are defined as dystonias that are accompanied by neurologic or systemic manifestations beyond movement disorders. Many syndromes or diseases can present with complex dystonia, either as the cardinal sign or as part of a multi-systemic manifestation. Complex dystonia often gradually develops in the disease course, but can also be present from the outset. If available, the diagnostic workup, disease-specific treatment, and management of patients with complex dystonias require a multi-disciplinary approach. This article summarizes current knowledge on complex dystonias with a particular view of recent developments with respect to advances in diagnosis and management, including causative treatments.

Keywords: Complex dystonia; Diagnostic; Infantile cerebral palsy; Management; NBIA; Red flags.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Proposal for diagnostic workup in suspected complex dystonias
Fig. 2
Fig. 2
Red flags for treatable diseases with complex dystonia; A = onset in adulthood; C = childhood-onset
See this image and copyright information in PMC

References

    1. Akcakaya NH, Haryanyan G, Mercan S, Sozer N, Ali A, Tombul T, Ozbek U, Ugur Iseri SA, Yapici Z. Clinical and genetic spectrum of an orphan disease MPAN: a series with new variants and a novel phenotype. Neurol Neurochir Pol. 2019;53(6):476–483. doi: 10.5603/PJNNS.a2019.0062. - DOI - PubMed
    1. Ala A, Borjigin J, Rochwarger A, Schilsky M. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology. 2005;41(3):668–670. doi: 10.1002/hep.20601. - DOI - PubMed
    1. Albanese A, Asmus F, Bhatia KP, Elia AE, Elibol B, Filippini G, Gasser T, Krauss JK, Nardocci N, Newton A, Valls-Sole J. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol. 2011;18(1):5–18. doi: 10.1111/j.1468-1331.2010.03042.x. - DOI - PubMed
    1. Alfadhel M, Almuntashri M, Jadah RH, Bashiri FA, Al Rifai MT, Al Shalaan H, Al Balwi M, Al Rumayan A, Eyaid W, Al-Twaijri W. Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases. Orphanet J Rare Dis. 2013;8:83. doi: 10.1186/1750-1172-8-83. - DOI - PMC - PubMed
    1. Alter AS, Engelstad K, Hinton VJ, Montes J, Pearson TS, Akman CI, De Vivo DC. Long-term clinical course of Glut1 deficiency syndrome. J Child Neurol. 2015;30(2):160–169. doi: 10.1177/0883073814531822. - DOI - PubMed

Publication types